CTI BioPharma Corp. (CTIC) |
| 9.095 0.005 (0.06%) 06-23 15:58 |
| Open: | 9.1 |
| High: | 9.1 |
| Low: | 9.09 |
| Volume: | 5,558,437 |
| Market Cap: | 1,199(M) |
| PE Ratio: | -16.84 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 8.84 |
| Resistance 1: | 8.17 |
| Pivot price: | 7.97 |
| Support 1: | 7.10 |
| Support 2: | 5.91 |
| 52w High: | 9.1 |
| 52w Low: | 4.01 |
CTI BioPharma Corp. is a biopharmaceutical company dedicated to the discovery, advancement, and commercialization of innovative, targeted treatments for blood cancers within the United States. Its key product is VONJO (pacritinib), an oral kinase inhibitor currently under investigation, specifically designed to target JAK2, FLT3, IRAK1, and CSF1R for the management of adult patients with myelofibrosis. The company holds licensing and collaboration agreements with Teva Pharmaceutical Industries Ltd., SBIO Pte Ltd., and Baxalta. Established in 1991 and based in Seattle, Washington, CTI BioPharma Corp. was previously known as Cell Therapeutics, Inc., adopting its current name in May 2014.
Financials
| EPS | -0.580 |
| Book Value | 9.610 |
| PEG Ratio | 0.00 |
| Gross Profit | 2.565 |
| Profit Margin (%) | -5.77 |
| Operating Margin (%) | -0.89 |
| Return on Assets (ttm) | 0.3 |
| Return on Equity (ttm) | -6.3 |
Company news
Wed, 24 Apr 2024
CTI BioPharma Corp (NASDAQ: CTIC) - Share Price - intelligentinvestor.com.au
Tue, 30 May 2023
CTI BioPharma Announces Cancellation of its 2023 Annual Meeting of Stockholders - PR Newswire
Wed, 10 May 2023
Sobi to Acquire CTI BioPharma - PR Newswire
Mon, 06 Mar 2023
CTI BioPharma Reports Fourth Quarter and Full Year 2022 Financial Results - PR Newswire
Fri, 06 Jan 2023
Matthew D Perry Net Worth (2026) - GuruFocus
Thu, 31 Mar 2022
CTI BioPharma (CTIC) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
